Trial intelligence / Profile preview

SVF Transplantation for Expanded Skin Regeneration

NCT07114692Not yet recruiting

Sponsor
Shanghai Ninth People's Hospital
Start
Sep 2025
Primary completion
Sep 2027
Modality
Stem Cell Therapies
01

Overview

Randomised, open-label trial of adipose stromal vascular components + extracellular matrix gel in dermal atrophy (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Dermal thickness at 8 weeks. Planned start Sep 2025; status: not yet recruiting.

02

Drugs

adipose stromal vascular components + extracellular matrix gel
03

Conditions

dermal atrophy

Beyond the preview

Go deeper on NCT07114692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07114692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call